Evidence map›Paper›PMID 32681036›Full record

ArticleNature communications2020

MG53 suppresses interferon-β and inflammation via regulation of ryanodine receptor-mediated intracellular calcium signaling.

Matthew Sermersheim, Adam D Kenney, Pei-Hui Lin, Temet M McMichael, Chuanxi Cai, Kristyn Gumpper, T M Ayodele Adesanya, Haichang Li, Xinyu Zhou, Ki-Ho Park and 2 more

Open access · goldAbstract readVideo-Audio Media
In one paragraph

Article in Nature communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 70 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Anti-TRIM72 Autoantibodies in Idiopathic Inflammatory Myopathies.medRxiv : the preprint server for health sciences · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Matthew SermersheimDepartment of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID http://orcid.org/0000-0003-3252-0986
Adam D KenneyDepartment of Microbial Infection and Immunity, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Pei-Hui LinDepartment of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID http://orcid.org/0000-0002-3894-5099
Temet M McMichaelDepartment of Microbial Infection and Immunity, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Chuanxi CaiDepartment of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID http://orcid.org/0000-0003-0532-7435
Kristyn GumpperDepartment of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID http://orcid.org/0000-0003-2704-1868
T M Ayodele AdesanyaDepartment of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID http://orcid.org/0000-0002-3897-2468
Haichang LiDepartment of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Xinyu ZhouDepartment of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID http://orcid.org/0000-0002-1606-5816
Ki-Ho ParkDepartment of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA.ORCID http://orcid.org/0000-0002-6193-9826
Jacob S YountDepartment of Microbial Infection and Immunity, The Ohio State University Wexner Medical Center, Columbus, OH, USA. jacob.yount@osumc.edu.
Jianjie MaDepartment of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, USA. jianjie.ma@osumc.edu.ORCID http://orcid.org/0000-0003-3865-6112
The Ohio State University Wexner Medical Center · US

Funding

Mechanisms of innate resistance to virus infectionsR01AI130110 · NIAID · OHIO STATE UNIVERSITY · PI Jacob Yount · 2017 to 2026
$4.3M
MG53-Mediated Membrane Repair in Muscle Physiology and DiseaseR01AR061385 · NIAMS · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI LIN, PEI-HUI · 2011 to 2020
$3.8M
Protein therapy to treat virus induced cardiopulmonary injuryR01HL157215 · NHLBI · UNIVERSITY OF VIRGINIA · PI CAI, CHUANXI, MA, JIANJIE · 2022 to 2025
$2.7M
Ca signaling cross-talk from SR to mitochondria in heart muscleR01HL138570 · NHLBI · OHIO STATE UNIVERSITY · PI LIN, PEI-HUI, ZHOU, JINGSONG · 2018 to 2021
$2.6M
Targeting cell membrane repair for treatment of acute kidney injuryR01DK106394 · NIDDK · OHIO STATE UNIVERSITY · PI LIN, PEI-HUI, ROVIN, BRAD H · 2016 to 2020
$2.5M
Integrative Training in Biomedical SystemsT32GM068412 · NIGMS · OHIO STATE UNIVERSITY · PI PARVIN, JEFFREY D · 2005 to 2020
$2.4M
Myokine function of MG53 in muscle injury-repair and regenerationR01AR070752 · NIAMS · OHIO STATE UNIVERSITY · PI HAN, RENZHI · 2017 to 2021
$1.7M
Inhibition of cell-to-cell fusion by interferon-induced proteinsR21AI142256 · NIAID · OHIO STATE UNIVERSITY · PI YOUNT, JACOB · 2019 to 2020
$429k
Mechanisms of Cardioprotection by the Innate Immune System During Influenza Virus InfectionsR21AI146690 · NIAID · OHIO STATE UNIVERSITY · PI RAJARAM, MURUGESAN, YOUNT, JACOB · 2019 to 2020
$415k
NHLBI NIH HHS R01 HL138570NHLBI NIH HHS R01 HL157215NIAID NIH HHS R01 AI130110NIAID NIH HHS R21 AI142256NIAID NIH HHS R21 AI146690NIAMS NIH HHS R01 AR061385NIAMS NIH HHS R01 AR070752NIDDK NIH HHS R01 DK106394NIGMS NIH HHS T32 GM068412
6 · The paper itself

Abstract

TRIM family proteins play integral roles in the innate immune response to virus infection. MG53 (TRIM72) is essential for cell membrane repair and is believed to be a muscle-specific TRIM protein. Here we show human macrophages express MG53, and MG53 protein expression is reduced following virus infection. Knockdown of MG53 in macrophages leads to increases in type I interferon (IFN) upon infection. MG53 knockout mice infected with influenza virus show comparable influenza virus titres to wild type mice, but display increased morbidity accompanied by more accumulation of CD45+ cells and elevation of IFNβ in the lung. We find that MG53 knockdown results in activation of NFκB signalling, which is linked to an increase in intracellular calcium oscillation mediated by ryanodine receptor (RyR). MG53 inhibits IFNβ induction in an RyR-dependent manner. This study establishes MG53 as a new target for control of virus-induced morbidity and tissue injury.

Indexed as

AnimalsCalcium SignalingCell Line, TumorDisease Models, AnimalGene Knockdown TechniquesGene Knockout TechniquesHumansImmunity, InnateInfluenza A Virus, H1N1 SubtypeInfluenza, HumanInterferon-betaMacrophagesMaleMembrane ProteinsMiceMice, KnockoutInterferon-betaMembrane ProteinsMG53 protein, mouseNF-kappa BRNA, Small InterferingRyanodine Receptor Calcium Release ChannelTRIM72 protein, humanTripartite Motif Proteins

Identifiers

PMID32681036
PMCPMC7368064
OpenAlexW3043541773

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.